Labor shortages and staff burnout among nurses are reasons to be wary of AMN Healthcare Services AMN stock despite the company’s favorable long-term prospects.
Correlating with this cautious scenario, AMN’s stock currently carries a Zacks Rank #5 (Strong Sell) and lands the Bear of the Day.
Declining Nurse and Allied Solutions Segment Sales
Providing total talent solutions and staffing networks for healthcare organizations, AMN’s Nurse and Allied Solutions segment revenue fell -38% last quarter to $538 million with the company stating its travel nurse sales fell -40% specifically.
AMN was still able to beat Q4 top and bottom line expectations in February but this is concerning considering the Nurse and Allied Solutions segment makes up more than half of its total revenue.
Furthermore, the impact of challenging work conditions and high turnover particularly among "Nurse Leaders" is lingering with AMN forecasting its Nurse and Allied Solutions segment revenue to be down 36-38% for the first quarter. AMN projects its consolidated revenue for Q1 to be 26-28% lower with Zacks estimates of $814.46 million representing a -27% decline.
Bottom Line Effect
With the proponents of nurse staffing making up such a large chunk of AMN’s core business, the company’s bottom line is expected to be impacted as well. Notably, earnings estimate revisions have declined -20% for fiscal 2024 over the last 30 days from projections of $4.93 per share to $3.97 a share.
Plus, FY25 EPS estimates have fallen -14% in the last month which is starting to put a dent in the hopes of a sharp rebound in AMN’s bottom line next year.
Takeaway
AMN’s stock is already down -20% year to date and a rebound may not come until its Nurse and Allied Solutions segment sales begin to stabilize. This will need to be monitored by investors going forward and for now, AMN’s stock is one to avoid.
Only $1 to See All Zacks' Buys and Sells
We're not kidding.
Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.
Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.
See Stocks Now >>
Labor shortages and staff burnout among nurses are reasons to be wary of AMN Healthcare Services AMN stock despite the company’s favorable long-term prospects.
Correlating with this cautious scenario, AMN’s stock currently carries a Zacks Rank #5 (Strong Sell) and lands the Bear of the Day.
Declining Nurse and Allied Solutions Segment Sales
Providing total talent solutions and staffing networks for healthcare organizations, AMN’s Nurse and Allied Solutions segment revenue fell -38% last quarter to $538 million with the company stating its travel nurse sales fell -40% specifically.
AMN was still able to beat Q4 top and bottom line expectations in February but this is concerning considering the Nurse and Allied Solutions segment makes up more than half of its total revenue.
Furthermore, the impact of challenging work conditions and high turnover particularly among "Nurse Leaders" is lingering with AMN forecasting its Nurse and Allied Solutions segment revenue to be down 36-38% for the first quarter. AMN projects its consolidated revenue for Q1 to be 26-28% lower with Zacks estimates of $814.46 million representing a -27% decline.
Bottom Line Effect
With the proponents of nurse staffing making up such a large chunk of AMN’s core business, the company’s bottom line is expected to be impacted as well. Notably, earnings estimate revisions have declined -20% for fiscal 2024 over the last 30 days from projections of $4.93 per share to $3.97 a share.
Plus, FY25 EPS estimates have fallen -14% in the last month which is starting to put a dent in the hopes of a sharp rebound in AMN’s bottom line next year.
Takeaway
AMN’s stock is already down -20% year to date and a rebound may not come until its Nurse and Allied Solutions segment sales begin to stabilize. This will need to be monitored by investors going forward and for now, AMN’s stock is one to avoid.
Only $1 to See All Zacks' Buys and Sells
We're not kidding.
Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.
Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.
See Stocks Now >>
Get the latest research report on AMN - FREE